Revisiting six established practices in the treatment of chronic myeloid leukaemia
Author:
Publisher
Elsevier BV
Subject
Hematology
Reference34 articles.
1. Chronic myeloid leukaemia;Kantarjian,2022
2. Long-term outcomes of imatinib treatment for chronic myeloid leukaemia;Hochhaus;N Engl J Med,2017
3. Relative survival in patients with chronic-phase chronic myeloid leukaemia in the tyrosine-kinase inhibitor era: analysis of patient data from six prospective clinical trials;Sasaki;Lancet Haematol,2015
4. Early response with dasatinib or imatinib in chronic myeloid leukaemia: 3-year follow-up from a randomized phase 3 trial (DASISION);Jabbour;Blood,2014
5. Early molecular response predicts outcomes in patients with chronic myeloid leukaemia in chronic phase treated with frontline nilotinib or imatinib;Hughes;Blood,2014
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Choosing the Best Firstline Drug: Does Efficacy Make You Think About Cost?;Clinical Lymphoma Myeloma and Leukemia;2024-09
2. Optimal frontline therapy of chronic myeloid leukemia today, and related musings;American Journal of Hematology;2024-08-02
3. Chronic myeloid leukemia: 2025 update on diagnosis, therapy, and monitoring;American Journal of Hematology;2024-08-02
4. Results of ponatinib as frontline therapy for chronic myeloid leukemia in chronic phase;Cancer;2024-05-28
5. Ponatinib‐review of historical development, current status, and future research;American Journal of Hematology;2024-05-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3